Domov › Prekomerna telesna teža › Pennsylvania › Philadelphia

Klinične študije za Prekomerna telesna teža v Philadelphia, PA

14 študij za Prekomerna telesna teža išče udeležence na lokacijah v Philadelphia in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Vključevanje udeležencevFaza 3

Abington Medical Specialists, Horsham · 16 mi stran
Family Practice Associates, Wilmington · 25 mi stran

Starost 45–99 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07037433

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Vključevanje udeležencevFaza 3

Clinical Renal Associates Ltd., Media · 12 mi stran
Suburban Research Associates, West Chester · 24 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Vključevanje udeležencevFaza 3

Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia

Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Vključevanje udeležencevFaza 3

Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia

Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937086

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Vključevanje udeležencevFaza 3

Keystone Clinical Studies, Plymouth Meeting · 12 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07353931

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Vključevanje udeležencevFaza 3

AURORA-2 Clinical Site, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 3

AURORA-1 Clinical Site, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Vključevanje udeležencevFaza 3

Suburban Research Associates - West Chester Office, West Chester · 24 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci

ACCOMPLISH-2 Research Site, Philadelphia

Starost 18–79 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Vključevanje udeležencevFaza 3

UPA Ctr Weight and Eating Dis, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07770841

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Vključevanje udeležencevFaza 4

Dermatology Associates of Plymouth Meeting, Plymouth Meeting · 12 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT06857942

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3

Research Site, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Vključevanje udeležencevFaza 3

ACCOMPLISH-1 Research Site, Philadelphia

Starost 18–79 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07654361

An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents

Vključevanje udeležencevVabljeni zdravi prostovoljci

Drexel University, Philadelphia

Starost 14–19 · Ženske · Posodobljeno 20. jul. 2026 · NCT06147973

Študije za Prekomerna telesna teža v drugih mestih

Druge študije v Philadelphia

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.